claim
The lack of commercial applications for engineered microbes in bioremediation is attributed to difficulties in engineering microbes that can outcompete native organisms while targeting recalcitrant pollutants, a lack of field trials, regulatory hurdles, and safety and containment concerns regarding the release of genetically modified organisms (GMOs).

Authors

Sources

Referenced by nodes (1)